EGFR kinase inhibitor and preparation method and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10710979
APP PUB NO 20180346444A1
SERIAL NO

15763156

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an EGFR kinase inhibitor and a preparation method and use thereof. Specifically, the present invention provides a compound as shown in formula (I), the definition of each group therein being as described in the description. Said compound is an efficient EGFR inhibitor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZHEJIANG BOSSAN PHARMACEUTICAL CO LTDHANGZHOU ZHEJIANG 311121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cai, Dongpo Zhejiang, CN 2 0
Ma, Dawei Zhejiang, CN 34 40
Wang, Kailiang Zhejiang, CN 6 44
Xia, Hongguang Zhejiang, CN 4 0
Xia, Shanghua Zhejiang, CN 5 0
Yu, Qiang Zhejiang, CN 149 2975
Yuan, Junying Zhejiang, CN 55 499
Zhang, Chen Zhejiang, CN 745 3564

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 14, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 14, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00